Pharma and laboratory592674-2026

Czechia – Blood substitutes and perfusion solutions – Roztoky a spotřební materiál pro hemofiltraci

Fakultní nemocnice Hradec Králové

Buyer country

Czechia

Publication date

Not specified

Biderra sector

Pharma and laboratory

Data source

TED open data

Decision signals

First-pass opportunity review

These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.

Timing signal
Deadline not indexed

Check the official notice

Indexed data completeness
86%

Based on seven decision fields

Official title coverage
7 languages

Preserved from source-supplied versions

Classification signal
33621400

Medical equipment, pharmaceuticals and personal care products

Official title versions

TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.

Spanish

Chequia – Sustitutos del plasma y soluciones para infusión – Roztoky a spotřební materiál pro hemofiltraci

Dutch

Tsjechië – Bloedvervangende middelen en bloedtransfusie-oplossingen – Roztoky a spotřební materiál pro hemofiltraci

Polish

Czechy – Substytuty krwi i roztwory do perfuzji – Roztoky a spotřební materiál pro hemofiltraci

French

Tchéquie – Substituts de plasma sanguin et solutions pour perfusions – Roztoky a spotřební materiál pro hemofiltraci

German

Tschechien – Blutersatzmittel und Perfusionslösungen – Roztoky a spotřební materiál pro hemofiltraci

Italian

Cechia – Sostituti ematici e soluzioni per perfusioni – Roztoky a spotřební materiál pro hemofiltraci

English

Czechia – Blood substitutes and perfusion solutions – Roztoky a spotřební materiál pro hemofiltraci

What Biderra adds

For notice 592674-2026, Biderra has normalized the contracting authority country as Czechia, grouped CPV 33621400 under pharma and laboratory, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.